Abstract
Perisynaptic Schwann cells (PSCs) are specialized, non-myelinating, synaptic glia of the neuromuscular junction (NMJ), that participate in synapse development, function, maintenance, and repair. The study of PSCs has relied on an anatomy-based approach, as the identities of cell-specific PSC molecular markers have remained elusive. This limited approach has precluded our ability to isolate and genetically manipulate PSCs in a cell specific manner. We have identified neuron-glia antigen 2 (NG2) as a unique molecular marker of S100b+ PSCs in skeletal muscle. NG2 is expressed in Schwann cells already associated with the NMJ, indicating that it is a marker of differentiated PSCs. Using a newly generated transgenic mouse in which PSCs are specifically labeled, we show that PSCs have a unique molecular signature that includes genes known to play critical roles in PSCs and synapses. These findings will serve as a springboard for revealing drivers of PSC differentiation and function.
Cite
CITATION STYLE
Castro, R., Taetzsch, T., Vaughan, S. K., Godbe, K., Chappell, J., Settlage, R. E., & Valdez, G. (2020). Specific labeling of synaptic schwann cells reveals unique cellular and molecular features. ELife, 9, 1–19. https://doi.org/10.7554/eLife.56935
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.